● Kills mycoplasma and is currently the most sensitive drug against mycoplasma in the world.● Inhibits the replication of porcine reproductive and respiratory syndrome (PRRS) virus.● Has a specific therapeutic effect on porcine ileitis.● Enhances the nonspecific immunity of pig herds: Promotes the metabolic capacity of macrophages, accelerates the differentiation of monocytes into macrophages, significantly increases the number of macrophages, boosts the quantity of lysosomal proteins within macrophages, and strengthens the body's immune response.● Effectively prevents and controls sudden death syndrome: Tylvalosin is highly sensitive to Clostridium perfringens type A.

High purity, dissolves in 15 seconds.

● Excellent targeting: Rapidly reaches the mycoplasma infection site—bronchial epithelial cells—via white blood cells to eliminate mycoplasma. It is the only animal-specific antibiotic that can truly and effectively reach the bronchial lumen to kill mycoplasma.

● Significant efficacy: Well-absorbed after oral administration, rapidly achieving effective blood drug concentrations. Exhibits higher potency against Mycoplasma hyopneumoniae, Lawsonia intracellularis, Actinobacillus pleuropneumoniae, and spirochetes.

● Green, safe, and environmentally friendly: Requires the lowest dosage among all drugs, with rapid metabolism, shortening the recovery time of sick pigs. Solves the problems of drug resistance and residues associated with tylosin, making it eco-friendly, safe, and reliable.

● Antiviral and antibacterial: Tylvalosin is the only optimal western medicine against PRRS (porcine reproductive and respiratory syndrome), with a potency 10 times that of tilmicosin. It quickly enters and accumulates in various tissues (especially lung and intestinal tissues) and has a wide distribution in the body. Additionally, its metabolite (3-AT) possesses antibacterial activity, exerting a post-antibiotic effect.